The outcomes of a scientific trial at Keio University present that administering hydrogen-added oxygen to a affected person transported to an emergency hospital after cardiac arrest has the next survival price than administering regular oxygen. group has introduced. In the long run, we goal to commercialize the therapy.
According to statistics from the Fire and Disaster Management Agency of the Ministry of Internal Affairs and Communications, there are roughly 80,000 individuals in Japan annually who’re transported to emergency medical establishments as a consequence of cardiac arrest as a consequence of coronary heart illness. In many circumstances, extreme sequelae stay.